picolinic acid has been researched along with Adverse Drug Event in 1 studies
picolinic acid: iron-chelating agent that inhibits DNA synthesis; may interfere with iron-dependent production of stable free organic radical which is essential for ribonucleotide reductase formation of deoxyribonucleotides; RN given refers to parent cpd; structure in Merck Index, 9th ed, #7206
picolinic acid : A pyridinemonocarboxylic acid in which the carboxy group is located at position 2. It is an intermediate in the metabolism of tryptophan.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hininger, I | 1 |
| Benaraba, R | 1 |
| Osman, M | 1 |
| Faure, H | 1 |
| Marie Roussel, A | 1 |
| Anderson, RA | 1 |
1 other study available for picolinic acid and Adverse Drug Event
| Article | Year |
|---|---|
Safety of trivalent chromium complexes: no evidence for DNA damage in human HaCaT keratinocytes.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Carcinogens, Environmental; Cell Survival; Cells, Cultured; Chlorides; | 2007 |